Cited by 157Monoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approachesComputational Drug Discovery Methods

Antibody complementarity determining region design using high-capacity machine learning

Open access
Liu, Ge, Zeng, Haoyang, Mueller, Jonas, Carter, Brandon, Wang, Ziheng, Schilz, Jonas, Horny, Geraldine, Birnbaum, Michael E +2 more·2020·Bioinformatics

Published version of a preprint

Abstract

MOTIVATION: The precise targeting of antibodies and other protein therapeutics is required for their proper function and the elimination of deleterious off-target effects. Often the molecular structure of a therapeutic target is unknown and randomized methods are used to design antibodies without a model that relates antibody sequence to desired properties. RESULTS: Here, we present Ens-Grad, a machine learning method that can design complementarity determining regions of human Immunoglobulin G antibodies with target affinities that are superior to candidates derived from phage display panning experiments. We also demonstrate that machine learning can improve target specificity by the modular composition of models from different experimental campaigns, enabling a new integrative approach to improving target specificity. Our results suggest a new path for the discovery of therapeutic molecules by demonstrating that predictive and differentiable models of antibody binding can be learned from high-throughput experimental data without the need for target structural data. AVAILABILITY AND IMPLEMENTATION: Sequencing data of the phage panning experiment are deposited at NIH's Sequence Read Archive (SRA) under the accession number SRP158510. We make our code available at https://github.com/gifford-lab/antibody-2019. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bioinformatics/btz895

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Carter B. et al (2019b) What made you do this? Understanding black-box decisions with sufficient input subsets. In The 22nd International Conference on Artificial Intelligence and Statistics, pp. 567– 576.
  2. Lakshminarayanan B. et al (2017) Simple and scalable predictive uncertainty estimation using deep ensembles In: Guyon, I. et al. (eds.) Advances in The 31st Neural Information Processing Systems, Long Beach, CA, USA, pp. 6402– 6413.
  3. O’Brien P.M., Aitken R. (2004) Antibody Phage Display: Methods and Protocols. Springer Science & Business Media, Heidelberg, New York.

Cited by

Sorted by citations

Authors
Liu, G., Zeng, H., Mueller, J., Carter, B., Wang, Z., Schilz, J., Horny, G., Birnbaum, M. E., Ewert, S., & Gifford, D. K.
Affiliations
  • MIT Computer Science and Artificial Intelligence Laboratory (US)
  • Novartis (Switzerland) (CH)
  • Koch Institute for Integrative Cancer Research At MIT (US)
Corresponding author
  • Liu, Ge
  • Gifford, David K
Venue
Bioinformatics
Published
2019-11-28
Volume
36
Issue
7
Pages
2126-2133
ISSN
  • 1367-4803 (ISSN-L)
  • 1367-4811
OpenAlex
W2990497243
Cited by
157
References
27
Citations by year
2026: 13 · 2025: 27 · 2024: 27 · 2023: 29 · 2022: 26 · 2021: 23 · 2020: 9 · 2019: 2
FWCI
9.90
Type
journal article
Language
en
Open access
Locations
  • Bioinformatics (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (R01CA218094)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
Keywords
antibody design, hypervariable region, human immunoglobulin G, target specificity, differentiable models, therapeutic antibodies
MeSH terms
Machine Learning, Antibodies, Humans, Complementarity Determining Regions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review